Published mark

ARDELYX, INC.

NASDAQ: ARDX. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:114791be-c7cd-403a-9868-dce7752ea1af
SEC CIK
0001437402
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
Newest evidence
May 3, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Michael RaabSince Apr 29, 2026
Chair
Not published
Independent
7 / 88 directors published
Published claims
314 distinct sources
Evidence records
150 pinned
Source conflicts
0None open

Built from 4 distinct sources and 15 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Eric Foster executive of ARDELYX, INC., effective 2026-04-29.

EffectiveEffective Apr 29, 2026E4

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Commercial OfficerEric FosterApr 2026currentSource reportedE4
Chief Legal OfficerFelecia EttenbergApr 2026currentSource reportedE5
Chief Human Resources OfficerJames BradyApr 2026currentSource reportedE6
Chief Technical and Quality OfficerJohn BishopApr 2026currentSource reportedE7
Chief Patient OfficerLaura WilliamsApr 2026currentSource reportedE9
Chief Business OfficerMichael KelliherApr 2026currentSource reportedE10
President, Chief Executive Officer and DirectorMichael RaabApr 2026currentSource reportedE11
Chief Medical OfficerRajani DinavahiApr 2026currentSource reportedE13
Chief Financial OfficerSusan HohenleitnerApr 2026currentSource reportedE14
Chief Legal and Administrative OfficerElizabeth GrammerNot capturedunknownSource reportedE3
Chief Financial and Operations OfficerJustin RenzNot capturedunknownSource reportedE8
Executive Vice President, Corporate Development and StrategyMike KelliherNot capturedunknownSource reportedE12

Board of directors

Evidence

8 directors published. 7 of 8 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
David MottIndependent2009Compensation, chairCompensation · ChairSource reportedE2
Merdad Parsey, M.D., Ph.D.Independent2025None publishedSource reportedE2
Michael RaabNot independent2008None publishedSource reportedE2
Muna Bhanji, R.PhIndependent2021None publishedSource reportedE2
Onaiza Cadoret-ManierIndependent2020Nominating and GovernanceSource reportedE2
Richard RodgersIndependent2014CompensationSource reportedE2
Robert BazemoreIndependent2016CompensationSource reportedE2
Walt A. Linscott, Esq.Independent2015Nominating and Governance, chairNominating and Governance · ChairSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
CompensationDavid MottDavid Mott, Richard Rodgers, Robert BazemoreNot described in the published record
Compensation · ChairNot publishedDavid MottNot described in the published record
Nominating and GovernanceWalt A. Linscott, Esq.Walt A. Linscott, Esq., Onaiza Cadoret-ManierNot described in the published record
Nominating and Governance · ChairNot publishedWalt A. Linscott, Esq.Not described in the published record
Committee RecordCompensation: Chair David Mott; Members David Mott (Chair); Richard Rodgers; Robert Bazemore
Committee AppointmentDavid Mott: chair, Compensation
Committee AppointmentRichard Rodgers: member, Compensation
Committee AppointmentRobert Bazemore: member, Compensation
Committee RecordNominating and Governance: Chair Walt A. Linscott, Esq.; Members Walt A. Linscott, Esq. (Chair); Onaiza Cadoret-Manier
Committee AppointmentWalt A. Linscott, Esq.: chair, Nominating and Governance
Committee AppointmentOnaiza Cadoret-Manier: member, Nominating and Governance

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerMichael Raab, President, Chief Executive Officer and Director, from Apr 29, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingARDX (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameARDELYX, INC.
Entity StatusPublic listing published

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
15 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    sec proxy. Published Apr 30, 2025. Retrieved Apr 24, 2026. Cited by 8 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    ARDX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    ARDX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    ARDX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  13. E13
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  14. E14
    sec filing. Published Apr 29, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  15. E15
    board_seats. board seats. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026
  • Eric Foster executive of ARDELYX, INC., effective 2026-04-29.
  • Felecia Ettenberg executive of ARDELYX, INC., effective 2026-04-29.
  • James Brady executive of ARDELYX, INC., effective 2026-04-29.
  • John Bishop executive of ARDELYX, INC., effective 2026-04-29.
  • Laura Williams executive of ARDELYX, INC., effective 2026-04-29.
  • Michael Kelliher executive of ARDELYX, INC., effective 2026-04-29.
  • Michael Raab executive of ARDELYX, INC., effective 2026-04-29.
  • Rajani Dinavahi executive of ARDELYX, INC., effective 2026-04-29.
  • Susan Hohenleitner executive of ARDELYX, INC., effective 2026-04-29.
  • Merdad Parsey, M.D., Ph.D. seat on ARDELYX, INC., effective 2025-01-01.
  • Muna Bhanji, R.Ph seat on ARDELYX, INC., effective 2021-01-01.
  • Onaiza Cadoret-Manier seat on ARDELYX, INC., effective 2020-01-01.
  • Onaiza Cadoret-Manier member of Nominating and Governance, effective 2020-01-01.
  • Robert Bazemore seat on ARDELYX, INC., effective 2016-01-01.
  • Walt A. Linscott, Esq. seat on ARDELYX, INC., effective 2015-01-01.
  • Nominating and Governance · Chair committee of ARDELYX, INC., effective 2015-01-01.
  • Walt A. Linscott, Esq. member of Nominating and Governance · Chair, effective 2015-01-01.
  • Richard Rodgers seat on ARDELYX, INC., effective 2014-01-01.
  • Richard Rodgers member of Compensation, effective 2014-01-01.
  • David Mott seat on ARDELYX, INC., effective 2009-01-01.
  • Compensation · Chair committee of ARDELYX, INC., effective 2009-01-01.
  • David Mott member of Compensation · Chair, effective 2009-01-01.
  • Michael Raab seat on ARDELYX, INC., effective 2008-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:114791be-c7cd-403a-9868-dce7752ea1af, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/ardelyx-inc

Navigate

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:114791be-c7cd-403a-9868-dce7752ea1af
  • Cite this recordARDELYX, INC.
  • Copy canonical URLregistry.alpha.ac/companies/ardelyx-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    ARDELYX, INC.Company
  • Eric FosterPerson
  • Felecia EttenbergPerson
  • James BradyPerson
  • John BishopPerson
  • Laura WilliamsPerson
  • Michael KelliherPerson
  • Michael RaabPerson
  • Rajani DinavahiPerson
  • Susan HohenleitnerPerson
  • Elizabeth GrammerPerson
  • Justin RenzPerson
  • Mike KelliherPerson
  • David MottPerson
  • Merdad Parsey, M.D., Ph.D.Person
  • Michael RaabPerson
  • Muna Bhanji, R.PhPerson
  • Onaiza Cadoret-ManierPerson
  • Richard RodgersPerson
  • Robert BazemorePerson
  • Walt A. Linscott, Esq.Person
  • Sections
    OverviewARDELYX, INC.
  • MonitoringARDELYX, INC.
  • LeadershipARDELYX, INC.
  • BoardARDELYX, INC.
  • CommitteesARDELYX, INC.
  • Control and votingARDELYX, INC.
  • Authority to actARDELYX, INC.
  • FinancialsARDELYX, INC.
  • GovernanceARDELYX, INC.
  • RiskARDELYX, INC.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.